Lifecore Biomedical Inc (LFCR)
7.31
+0.33
(+4.73%)
USD |
NASDAQ |
Nov 22, 16:00
7.29
-0.02
(-0.27%)
Pre-Market: 20:00
Lifecore Biomedical Cash from Operations (Quarterly): -0.643M for Aug. 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -0.643M |
| May 31, 2024 | 8.64M |
| February 29, 2024 | -1.534M |
| November 30, 2023 | 1.006M |
| August 31, 2023 | -8.329M |
| May 31, 2023 | -2.262M |
| February 28, 2023 | -11.72M |
| November 30, 2022 | -2.353M |
| August 31, 2022 | -1.101M |
| May 31, 2022 | -0.548M |
| February 28, 2022 | -17.74M |
| November 30, 2021 | -5.137M |
| August 31, 2021 | 0.831M |
| May 31, 2021 | 5.871M |
| February 28, 2021 | -7.856M |
| November 30, 2020 | 1.435M |
| August 31, 2020 | 17.02M |
| May 31, 2020 | -12.70M |
| February 29, 2020 | 10.58M |
| November 30, 2019 | -9.483M |
| August 31, 2019 | -5.439M |
| May 31, 2019 | -1.429M |
| February 28, 2019 | 12.65M |
| November 30, 2018 | 2.617M |
| August 31, 2018 | 2.186M |
| Date | Value |
|---|---|
| May 31, 2018 | -0.521M |
| February 28, 2018 | 13.96M |
| November 30, 2017 | 2.886M |
| August 31, 2017 | 3.45M |
| May 31, 2017 | 6.657M |
| February 28, 2017 | 17.65M |
| November 30, 2016 | -0.94M |
| August 31, 2016 | 6.467M |
| May 31, 2016 | 14.33M |
| February 29, 2016 | 4.148M |
| November 30, 2015 | 4.047M |
| August 31, 2015 | -1.765M |
| May 31, 2015 | 13.24M |
| February 28, 2015 | 10.03M |
| November 30, 2014 | -0.593M |
| August 31, 2014 | 3.943M |
| May 31, 2014 | 7.211M |
| February 28, 2014 | 9.541M |
| November 30, 2013 | -0.245M |
| August 31, 2013 | 4.538M |
| May 31, 2013 | 7.755M |
| February 28, 2013 | 11.09M |
| November 30, 2012 | -2.701M |
| August 31, 2012 | 5.085M |
| May 31, 2012 | 13.65M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.74M
Minimum
Feb 2022
17.02M
Maximum
Aug 2020
-1.801M
Average
-1.318M
Median
Cash from Operations (Quarterly) Benchmarks
| AngioDynamics Inc | -18.25M |
| Precision Optics Corp Inc | -0.3186M |
| Sage Therapeutics Inc | -82.36M |
| Outset Medical Inc | -20.57M |
| NovaBay Pharmaceuticals Inc | -2.061M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.392M |
| Cash from Financing (Quarterly) | 1.093M |
| Free Cash Flow | -8.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1308 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | 1.325M |
| Free Cash Flow Yield | -3.41% |